Cryoport (CYRX.US) Price Target and Rating 2026/2027

0.00
Share this analysis:

Cryoport 2026 Price Target

The average price target for Cryoport is $22.33. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 0% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.
⚠️ Don’t buy a stock just because of its price targetA price target is the analysts’ estimate of where the stock will trade in 12 months. That estimate is often wrong. A large study of US stocks from 2000 to 2009 found that only 38% of price targets had been met after 12 months. On average, the targets promised 15 percentage points more return than the stocks delivered. Use the price target together with the financials and the trend, not on its own.Source: Bradshaw, Brown and Huang (2013)

Is Cryoport overvalued or undervalued?

Cryoport is currently fairly valued with a gap of 0% relative to the price target.


The current price is $0.00, which places Cryoport in the fairly valued category. The stock is considered undervalued when the price is below $20.10, and overvalued when the price exceeds $24.56.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Cryoport, the fair value range lies between $20.10 and $24.56.


See the full price target analysis for Cryoport →

Analyst Ratings for Cryoport stock in 2026: Strong Buy

9 analysts cover Cryoport. There is broad agreement on a positive view — 88.9% recommend buying.

Consensus: Strong Buy (4.67/5)
Strong Buy
7 (77.8%)
Buy
1 (11.1%)
Hold
1 (11.1%)
Strong Sell Sell Hold Buy Strong Buy
4.67 out of 5 based on 9 analysts

About Cryoport – Integrated Freight & Logistics

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee. Read more about the company

Key Figures for Cryoport

$1.0B Market cap
$192M Revenue
Integrated Freight & Logistics Industry
- P/E
5.41 P/S
2.41 P/B
United States Listed on exchange

What kind of stock is Cryoport?

Momentum stock

Cryoport is classified as a momentum stock with a momentum score in the top 3% of all stocks. The price has risen 0.0% over the long term.

Score Overview for Cryoport

💰 Value Score 20/100 (Low)
⭐ Quality Score 19/100 (Very Low)
🚀 Momentum Score 97/100 (Very High)
📊 Total Score 45/100

⚠️ 3 red flags identified 1 critical

Our analysis has identified 3 potential risk factors in Cryoport that investors should be aware of.

⚠️ Weak balance sheet (elevated risk): Altman Z2 is 0.51 – the balance sheet is measurably weaker than average. This is a risk signal based on the numbers, not a bankruptcy prediction.
🚨 Negative profit margin: The profit margin is -21.5% – the company is losing money on its operations.
⚠️ Negative return on equity: ROE is -7.4% – the company is generating a negative return for shareholders.

📈 Valuation

The P/S ratio is 5.4 (high — the market pays a premium for the revenue). The P/B ratio is 2.4. The PEG ratio is 62.13 — above 2.0 suggests the stock is expensive relative to its growth rate.

🏦 Financial Health

The Piotroski score is 4 out of 9 — average financial health. Altman Z2 is 0.51 (weak balance sheet — elevated risk). The debt-to-equity ratio (D/E) is 75.0% — low debt, a solid balance sheet.

🚀 Momentum & Short Interest

Short interest is 8.26% — elevated, some investors are betting on a decline.

Insider Trading in Cryoport 2026: Only sells

In 2026, insiders at Cryoport have made 20 transactions, all of which were sales. On a net basis, insiders took $5,508,845 out of the stock. Active insiders include SHELTON JERRELL, ZECCHINI EDWARD J, Mandalam Ramkumar and others.

Last 3 Months: No trades

There has been no insider trading in the last 3 months.

All Transactions: Only sells

Insiders have exclusively sold shares in the recent period. This can suggest management sees limited opportunity.

Across the last 20 transactions: 0 purchases and 20 sales. A net $5,508,845 out of the stock.

Latest sale: SHELTON JERRELL sold 28,800 shares at $14.91 each on 2026-08-11.

Who is selling: SHELTON JERRELL, ZECCHINI EDWARD J, Mandalam Ramkumar, STEFANOVICH ROBERT, Sawicki Mark W and others.

Latest Insider Trades in Cryoport (2026)

The table shows the last 20 reported insider transactions in Cryoport. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share (USD) Total amount (USD)
2026-08-11 SHELTON JERRELL Sell 28,800 14.91 429,408
2026-06-11 ZECCHINI EDWARD J Sell 33,600 14.47 486,192
2026-06-10 ZECCHINI EDWARD J Sell 1,400 15.23 21,322
2026-06-08 Mandalam Ramkumar Sell 23,214 15.44 358,424
2026-06-04 STEFANOVICH ROBERT Sell 169,427 16.27 2,756,577
2026-03-23 STEFANOVICH ROBERT Sell 1,094 8.18 8,949
2026-03-23 SHELTON JERRELL Sell 2,894 8.18 23,673
2026-03-23 Sawicki Mark W Sell 1,341 8.18 10,969
2026-03-16 ZECCHINI EDWARD J Sell 2,014 8.00 16,112
2026-03-16 STEFANOVICH ROBERT Sell 2,743 8.00 21,944

Who is buying and selling Cryoport shares in 2026?

The following insiders have sold shares: SHELTON JERRELL, ZECCHINI EDWARD J, Mandalam Ramkumar, STEFANOVICH ROBERT, Sawicki Mark W and others. In total, $5,508,845 was sold across 20 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Cryoport Short Selling 2026: 8.3% Sold Short

High short interest: 8.3% of the free float
Short % of free float
8.3%
Assessment
High short interest
Short squeeze risk
Moderate
Data source
EODHD
Reported about twice a month
The stock has a high share of short selling. Between 5-10% of the freely traded shares are sold short, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze.

What does this mean for you as an investor?
A short interest of 8.3% means that 8.3% of the freely traded shares in Cryoport have been borrowed and sold by investors betting on falling prices.

Short interest comes from our data provider EODHD. The figure is reported about twice a month; we check it every trading day.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
▲
8.3%

When Does Cryoport Report Earnings?

The next earnings date for Cryoport is not yet available. Check the company's investor calendar for more information.



Technical Analysis of Cryoport 2026 – Signal: Buy

Overall Technical Signal: Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated November 13, 2026.

Trend Analysis of Cryoport, Inc

Cryoport, Inc is in a short-term uptrend. The price of $20.10 is 10.9% above the 20-day average ($18.12). Medium term, the picture is positive: the price is 15.9% above the 50-day average ($17.35). Long term, the stock is 47.2% above the 200-day average ($13.66), which confirms a long-term uptrend.

Golden Cross: The 50-day average (17.35) is above the 200-day average (13.66), which is a classic bullish signal for Cryoport, Inc.

Is Cryoport, Inc overbought or oversold?

Cryoport, Inc has an RSI of 62.6. The stock shows positive momentum in the upper part of the neutral zone.

MACD Analysis for Cryoport, Inc

Daily MACD: MACD is positive (0.725), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is above the signal line (0.399) by 0.326, which confirms rising momentum in the uptrend.

Weekly MACD: MACD5 is positive (1.518), which indicates a broader bullish long-term trend. MACD5 is above the signal line (1.460) by 0.058, which confirms rising long-term momentum.

Overall MACD assessment: Both the daily and weekly MACD are positive and above their signal lines. Trend and momentum confirm each other across time horizons – the strongest bullish signal.

Risk Profile for Cryoport, Inc

Cryoport, Inc has an annual standard deviation of 50.8%, which classifies the stock as Speculative. Sizeable price swings are normal, and the stock requires a higher risk tolerance.

Overall Technical Conclusion for Cryoport, Inc

Trend: Neutral/mixed.

MACD trend (zero line): Daily bullish (0.725). Weekly bullish (1.518).

MACD momentum (signal): Daily rising. Weekly rising.

RSI: 62.6 – neutral.

Technical signal: Buy

The broader trend is positive and MACD supports the picture. Consider buying with a stop-loss below the nearest support level.

Who Owns Cryoport?

The three largest owners of Cryoport are BlackRock Inc (8.3%), Cadian Capital Management LP (5.8%) and Arnhold & S. Bleichroeder Advisers, LLC (5.0%). The percentage is their share of the stock, as of Jun 30, 2026. Source: our data provider EODHD.

The 10 Largest Institutions

InstitutionStakeChange
BlackRock Inc8.33%+6.0%
Cadian Capital Management LP5.77%−38.9%
Arnhold & S. Bleichroeder Advisers, LLC5.02%+241.4%
Assenagon Asset Management SA4.55%+54.1%
Morgan Stanley - Brokerage Accounts4.50%−50.3%
Vanguard Capital Management, LLC4.25%+1.6%
Millennium Management LLC3.41%−41.9%
Fred Alger Management, LLC3.05%−9.1%
Geode Capital Management, LLC2.59%+5.1%
Mak Capital One LLC2.52%−10.3%

As of Jun 30, 2026. "Change" is the change in shares held since the holder's previous report.

The 5 Largest Funds

FundStakeChange
Vanguard MStar Total Stk Mkt Idx Invest3.01%0.0%
iShares Russell 2000 ETF2.46%0.0%
First Eagle Small Cap Opportunity I2.20%−2.3%
Alger Small Cap Focus I2.11%0.0%
Calamos Timpani Small Cap Growth I1.19%−18.5%

As of Oct 30, 2026. A fund may be managed by one of the institutions above, so the two lists cannot be added together.

Frequently Asked Questions About Cryoport stock in 2026

Should you buy Cryoport stock now?
Yes, the technical signal for Cryoport is currently Buy. Cryoport trades at $0.00 as of Nov 13, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 0.725 with rising momentum (signal: 0.399); RSI is at 62.6 (neutral zone). This is a technical observation based on current data, not investment advice.
What is the price target for Cryoport stock?
There is currently no active analyst price target for Cryoport.
Is Cryoport a dividend stock?
No, Cryoport does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Cryoport stock?
Cryoport is rated as a stock in the risk category Speculative. the annual standard deviation is 50.8%, which classifies the stock as Speculative.
Is Cryoport overvalued?
Cryoport has the following valuation ratios: a P/S ratio of 5.4, a P/B ratio of 2.4.
Is Cryoport overbought?
No, Cryoport is not overbought. RSI is at 62.6 (neutral zone). The technical indicators show: RSI is at 62.6 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, MACD is positive with rising momentum (bullish).
When is the next Cryoport earnings report?
The date of the next earnings report for Cryoport has not been published yet. Check the company's investor calendar for updates.
Is Cryoport shorted?
Yes, Cryoport is shorted with 8.3% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Cryoport stock?
No, insiders are not buying Cryoport shares – they are net sellers. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 5,508,845 USD sold. Active sellers include SHELTON JERRELL, ZECCHINI EDWARD J, Mandalam Ramkumar and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Cryoport a good stock?
Based on our total score, Cryoport is rated as a mediocre stock with a total score of 45 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 20/100, Quality: 19/100, Momentum: 97/100. Whether now is the time to buy is a separate question: the technical signal is Buy. Whether Cryoport is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Cryoport stock?
The outlook for Cryoport based on current data: Detailed data is currently not available. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Cryoport stock moving?
Cryoport is moving right now. The technical indicators show: MACD is positive with rising momentum (bullish signal); short interest is 8.3% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Cryoport go?
There is currently no active analyst price target for Cryoport. The stock has traded between $7.61 and $21.78 over the last 52 weeks. The price is 100.0% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Cryoport fall?
We lack enough history to give a specific floor for Cryoport. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Cryoport do?
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopre... The company belongs to the Industrials sector, more specifically the Integrated Freight & Logistics industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Cryoport as an investment.
Did Cryoport raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Cryoport. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Cryoport making money or losing money?
No, Cryoport is currently not making money — the company is losing money with a negative profit margin of -21.5%, a substantial loss. That means the business loses money on every dollar of revenue. The operating margin (profit before interest and taxes) is also negative at -14.4% — so it is not just financing costs weighing on the result. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Cryoport go bankrupt?
The bankruptcy risk of Cryoport is rated as elevated. Altman Z2 (a model for assessing financial distress) is 0.51 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 4 — which is average. Debt relative to equity is 75% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Cryoport have a lot of debt?
No, Cryoport has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 75%. For the industrials sector, anything below 100% counts as low debt. Industrial companies often sit at 100-200% because of heavy production assets and long order books. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Cryoport service its debt? Could struggle to service its debt — the interest coverage ratio (how many times earnings can cover interest payments) is -19.6x, and the company has more cash than debt (net cash).

Other Stocks in Industrials

Compare Cryoport with other stocks in the industrials sector. Click a stock to see its technical analysis, insider trading and key figures.

See all 133 stocks in the Industrials sector